loader from loading.io

Solidarity Fridays - Week 8 with Dave McGaughey

Psychedelics Today

Release Date: 05/22/2020

Solidarity Fridays - Week 25 show art Solidarity Fridays - Week 25

Psychedelics Today

In today’s Solidarity Fridays episode, Joe and Kyle discuss recent items in the news and dive into cannabis-assisted psychotherapy after Joe recently helped with his first session. They discuss Compass Pathways' projection that their upcoming stock price could be $14-$16 a share, giving them a possible valuation of as much as $544 million and the problem of having Peter Thiel as one of their leading investors, as it has recently come to surface that he met with white nationalists in 2016 and had good things to say about them. This, in addition to his concerning data-mining company, Palantir...

info_outline
Ash - CBD, Nootropics, and Micro1p show art Ash - CBD, Nootropics, and Micro1p

Psychedelics Today

In this episode, Joe interviews Ash: Netherlands-based psychedelic entrepreneur with his hands in many psychedelic spaces- drug manufacturing company Synergy Trading, nootropics company Cerebra Nootropics, and podcast, Shifty Perspective.   Ash talks about his path from trying San Pedro on a farm, to trying DMT and living on the road and in squats for years, to moving to Belgium from the UK, to finding his way into the world of CBD after a friend recommended it for his epileptic girlfriend at the time. When she went from 12 seizures a day to none within a month of starting regular...

info_outline
Solidarity Fridays - Week 24 show art Solidarity Fridays - Week 24

Psychedelics Today

In today's Solidarity Fridays episode, Joe and Kyle discuss several recent items in the news that further the advancement of psychedelics, including: Canadian company Havn Lifescience following Compass Pathways' lead and registering with the Canadian Securities Exchange under the symbol HAVN, Amsterdam-based psychedelic retreat company Synthesis announcing that leading Clinical Psychologist Dr. Rosalind Watts has joined their advisory board (which also includes Dr. Robin Carhart-Harris, who joined in November), European psychedelic-assisted psychotherapy company AWAKN Life Sciences Inc....

info_outline
Wade Davis - Ayahuasca and a New Hope for Colombia show art Wade Davis - Ayahuasca and a New Hope for Colombia

Psychedelics Today

In this episode, Joe interviews Wade Davis: Ph.D., Professor of Anthropology at the University of British Columbia, explorer, ethnobotanist, star of the recent documentary, "El Sendero de la Anaconda," and author of several books, including  bestseller The Serpent and the Rainbow, which was optioned for a movie, starring Bill Pullman and released by Universal Pictures in 1988. His new book, Magdalena: River of Dreams: A Story of Colombia, comes out on September 15th.  Wade discusses his history with Richard Evans Schultes, the strange phenomenon behind the growth of ayahuasca...

info_outline
Solidarity Fridays - Week 23 show art Solidarity Fridays - Week 23

Psychedelics Today

In today's Solidarity Fridays episode, Joe and Kyle discuss recent items in the news. They cover a new LSD microdose trial to study the effects of 5, 10, or 20 µg on acute pain, seeing how long participants could hold their hands in 37.4° F water. Led by researchers from Maastricht University with help from the Beckley Foundation, this is the first study of its kind since Eric Kast first studied the effects of LSD on acute pain in the 1960s, and could help lead to LSD being prescribed for acute pain over the more standard and very addictive and dangerous opioids. This leads towards the topic...

info_outline
Sara Reed - Ketamine Therapy Through a Culturally Responsible Lens show art Sara Reed - Ketamine Therapy Through a Culturally Responsible Lens

Psychedelics Today

In this episode, Joe and Kyle interview Sara Reed, MS, LMFT, creator of Mind's Eye Health Solutions, and Director of Psychedelic Services at the Behavioral Wellness Clinic in Connecticut. Reed talks about her path to psychedelics- from graduating with a masters in emerging family therapy and wanting to do research specifically with black Americans, to working with Dr. Monica Williams and eventually MAPS, to being selected as one of the therapists for a phase 3 MDMA-assisted psychotherapy trial (which focused on people of color), to making the transition from practicing with MDMA to ketamine...

info_outline
Solidarity Fridays - Week 22 show art Solidarity Fridays - Week 22

Psychedelics Today

In today's Solidarity Fridays episode, Joe and Kyle have, in Joe's words, "a wildly rambling show." They cover topics in the news, including MAPS' recent completion of their Capstone Campaign, a non-profit fundraising effort to fund the final research required to seek FDA approval of MDMA-assisted psychotherapy (through which they raised $30 million from several high-profile names), MindMed's new LSD-MDMA "candy flipping" phase 1 trial set to commence later this year, Representative Earl Blumenauer's (D-OR) fundraising efforts for legal psilocybin and Oregon's ballot initiative becoming a...

info_outline
Dr. LaMisha Hill - The Fight for Diversity, Inclusion, and Equity show art Dr. LaMisha Hill - The Fight for Diversity, Inclusion, and Equity

Psychedelics Today

In this episode, Joe interviews Dr. LaMisha Hill, licensed Counseling Psychologist, board member of the Alameda County Psychological Association, and Director of Multicultural Affairs for the Office of Diversity and Outreach at the University of California, San Francisco. Hill talks about how race and gender of underrepresented people come into play in the psychedelic sphere- in studies, professions, and even in people's consideration of psychedelics as a possible healer for them: how most psychology follows the same well-worn, Euro-centric, fairly western, mostly-for-well-off-college-students...

info_outline
Solidarity Fridays - Week 21 show art Solidarity Fridays - Week 21

Psychedelics Today

In today's Solidarity Fridays episode, Joe and Kyle sit down and discuss recent items in the news, including the passing of Tav Sparks; author, therapist, co-director of Grof Transpersonal Training, and creator of "Movie Yoga," and scientist Jordi Riba; one of the early pioneers of ayahuasca research and one of the first ever to bring it into the lab.  They discuss the ayahuasca episode of the new Netflix docuseries "Unwell," and 2 articles from Marijuana Moment: psychedelic activists in Oakland creating a guideline for plant medicine healing ceremonies and the new initiative to allow for...

info_outline
Jerry and Julie Brown - Healing Through Mystical Experience show art Jerry and Julie Brown - Healing Through Mystical Experience

Psychedelics Today

In this episode, Joe interviews Jerry and Julie Brown. Jerry (Ph.D.) is an author and activist, who served as founding professor of anthropology at Florida International University in Miami for 42 years. Julie (M.A.) is an author and integrative psychotherapist, who worked with cancer patients with a focus on guided imagery. Together, they are co-authors of The Psychedelic Gospels: The Secret History of Hallucinogens in Christianity. They talk about their  on Psychedelics Today and inspiring studies: Walter Pahnke’s original psilocybin study at Marsh Chapel and Roland Griffiths’...

info_outline
 
More Episodes

In today’s Solidarity Friday’s Episode, Kyle and Joe interview Dave McGaughey, Founding Partner of NorthStar. In the show, they talk about NorthStar, Ethics, and the story, “We Will Call It Pala”.


Support the show

Navigating Psychedelics


Show Notes

About Dave

  • Dave was interested in natural food and kombucha and sold kombucha commercially and personally for 10 years
  • He mentions his favorite book of all time Island
  • The critical moment for Dave was at a convention hall on an escalator
    • On the escalator, in the middle, there were signs for an ‘exit’ that each company sold for
    • “What do we spend our short lives doing and why?” - Dave
    • He became humbled by the genius around him there and left the natural foods 'industry' for something more

Business Ethics

  • People come in with really good intentions, and then things get out of hand
  • Money screams security and comfort, even though that's not really the case
  • Joe says integrity has been Psychedelics Today’s number one goal, we've turned down investors that were not ethical, been pubic about partnerships (and the ending of some), etc
  • Reflect inward to maintain ethical standing
    • “How do we reflect on what we actually need and what we need to do?” - Joe
    • Since the beginning, Joe and Kyle would reach out to their advisory board for questions and guidance

Anchoring Community

  • At Northstar, they look at a large coalition of people in the psychedelic field
    • Pollanators - those who have read Pollan’s book and are super excited
    • Those who have had their own psychedelic experiences
    • Investors who are coming into the space and gaining a lot of power very quickly
    • Anchoring Community - the people who have been here for the longest time, and doing work in this space (elders, drug policy activists, etc)
  • In the underground, there is no strategy of how to hold accountability of facilitators, etc
  • “The eco-system is most thriving when non-profit pharma, and decrim and legalization are going really well” - David

Mindmed

  • Mindmed is making a drug that acts as a LSD Neutralizer technology to shorten and stop LSD trips
    • Dave says it could be really valuable for the ‘bad’ experiences
    • Another thing about the patent that might be bad for the community is that it says that trips are bad
  • He says Mindmed is specifically structured at doing something that may hurt the field

Book Reccomendations

  • Dave recommends two books that give insight on organizations and language use
    • Dave mentions a book that helps centrist people understand systemic issues around inequality, The Jungle
    • He recommends to the activist community, Nixonland, of the rise of the culture war

Consumer Education

  • It could be wise to have consumers decide the market
  • “The fact that the field is more precarious, actually puts more incentive to act ethically, especially for patient care.” - Dave
  • Dave says at NorthStar they ask, “In what ways do you build power to incentivize or pressure ethical action across the ecosystem at large?”
  • Joe says a lot of the stuff happening in psychedelics are by people that are underfunded and underpaid
  • NorthStar is not an industry association

NorthStar Pledge

  • It's a starting point to a dialogue on ethics
    • The NorthStar Pledge is on integrity and ethics
    • How do people in the field who care about this, talk about ethics?
  • Kyle says capitalism has influence on systemic issues
    • He says that people who embody psychedelic influences, are typically ethical
    • Being capitalistic, usually equates to bad ethics, but how do we embody the psychedelic wisdom to create a new model and change the capitalistic model to be more ethical?

Capitalism

  • Is capitalism really bad?
    • Imagine how capitalism would look if it were run by women and people of color, individuals who systematically don't operate with power
    • Imagine if companies were run by ethics, and not by money or power

Final Thoughts

  • At NorthStar, there are 3 women in high leadership positions
  • Dave wants to see more women and people of color in leadership positions
  • Dave says he is so proud by the leadership who runs NorthStar

Links

NorthStar

We Will Call it Pala


About Dave McGaughey

Dave McGaughey serves as Creative Director for Auryn Project, a non-profit incubator in the psychedelic field supporting heart-lead, highly effective organizations scaling equitable, affordable psychedelic medicine. He is a founding member of North Star, an initiative dedicated to centering integrity and ethics in the heart of the emerging psychedelic field, starting with the North Star Ethics Pledge. Dave is the author of We Will Call It Pala, a short work of graphic fiction exploring one potential future for psychedelic commercialization. Dave has done graphic design and web development for Auryn Project, North Star and Sage Integrative Health. Prior to psychedelics, Dave worked in Natural Foods and has brewed kombucha commercially and personally for more than ten years.

Designed to help the body with cellular energy and cardiovascular endurance.

Get a 30 day free audible trial at audibletrial.com/psychedelicstoday